[Effects of N-amidino-3,5-diamino-6-chloro-pyrazinecarboxamide (amiloride) on transport processes and metabolic capacities of adipose tissue].
D000273:Adipose Tissue / Q000187:drug effects / Q000378:metabolism*; D000818:Animals; D001692:Biological Transport; D002245:Carbon Dioxide / Q000378:metabolism; D002247:Carbon Isotopes; D003864:Depression, Chemical; D004232:Diuretics / Q000494:pharmacology*; D005947:Glucose / Q000378:metabolism*; D066298:In Vitro Techniques; D007328:Insulin / Q000494:pharmacology; D007930:Leucine / Q000378:metabolism; D014176:Protein Biosynthesis; D011719:Pyrazines / Q000494:pharmacology*; D051381:Rats
D002247:Carbon Isotopes; D004232:Diuretics; D007328:Insulin; D011719:Pyrazines; D002245:Carbon Dioxide; D007930:Leucine; D005947:Glucose
Wirkungen von N-Amidino-3,5-diamino-6-chloro-pyrazincarboxamid (Amilorid) auf Transportvorgänge und Stoffwechselleistungen des Fettgewebes.